北醫大以抗癌標靶新藥MPT0E028獲「2014臺北生技獎」金獎 暨科技部2年期重大臨床試驗專題研究計畫，補助金達3千2百萬元

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by

Cookie settings
Privacy policy
End User Agreement
Send Feedback

Options

北醫大以抗癌標靶新藥MPT0E028獲「2014臺北生技獎」金獎 暨科技部2年期重大臨床試驗專題研究計畫，補助金達3千2百萬元

北醫大以抗癌標靶新藥MPT0E028獲「2014臺北生技獎」金獎暨科技部2年期重大臨床試驗專題研究計畫，補助金達3千2百萬元